Academic Journal
Q1Journal of Molecular and Cellular Cardiology Plus
About Journal of Molecular and Cellular Cardiology Plus
Journal of Molecular and Cellular Cardiology Plus is a scholarly journal published by Elsevier B.V.. SCImago 2025 lists it in Q1, with an SJR of 0.758 and H-index of 8.
Coverage: 2022-2026. Research categories: Dentistry (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-04-27. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Cardiac Fibrosis and Remodeling; Cardiovascular Function and Risk Factors; Cardiomyopathy and Myosin Studies; Cardiac electrophysiology and arrhythmias; Congenital heart defects research; Mitochondrial Function and Pathology.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Heterogeneous nuclear ribonucleoprotein A1 as a candidate associated with pulmonary vascular remodeling in pulmonary arterial hypertension
Yoshihito Morimoto, Yoshiaki Sato, Katsuhiro Kato, Hidenori Yamamoto et al.
2026-12 · DOI: 10.1016/j.jmccpl.2026.100867Netrin-1 suppresses CCL2-driven macrophage migration: implications for modulating vascular inflammation and aortic sinus enlargement in hyperlipidaemic mice
Vasco Claro, Yanira Riffo-Vasquez, Fulye Argunhan, Albert Ferro et al.
2026-12 · DOI: 10.1016/j.jmccpl.2026.100868Evidence for a role of adverse sarcomere signaling in atrial fibrillation induction
Mark D. McCauley, R. John Solaro
2026-12 · DOI: 10.1016/j.jmccpl.2026.100866Systemic inflammation increases mast cell numbers in coronary arteries in patients who died from myocardial infarction
M.D. Fiet, W.W. Fuijkschot, L. Woudstra, R. van der Linden et al.
2026-12 · DOI: 10.1016/j.jmccpl.2026.100870CardioPharmaGENET (CA24165): A COST action network for advancing cardiovascular pharmacogenomics and precision medicine
Adna Ašić, Yvan Devaux, Miron Sopić, Amela Jusić et al.
2026-12 · DOI: 10.1016/j.jmccpl.2026.100869Systemic administration of the PRMT5 inhibitor GSK3326595 does not induce overt cardiotoxicity in the murine heart
Victoria Mauz, Clara Steinacher, Jürgen Burhenne, Kevin Steimel et al.
2026-12 · DOI: 10.1016/j.jmccpl.2026.100863Acetyl-CoA synthetase 2 maintains cytosolic acetyl-CoA homeostasis to preserve mitochondrial integrity and attenuate cardiac dysfunction under chronic β-adrenergic stress
Toranosuke Sekine, Shunsuke Miura, Tomofumi Misaka, Satoshi Okochi et al.
2026-12 · DOI: 10.1016/j.jmccpl.2026.100862PITX2C deficiency promotes arrhythmogenic remodelling via oxidative stress in atrial myocytes
Andy Kim, Sébastien Gauvrit, Frederick S. Vizeacoumar, Michelle M. Collins et al.
2026-09 · DOI: 10.1016/j.jmccpl.2026.100858Organelle network dysfunction in primary cardiomyopathy: An integrated perspective on pathogenesis and therapeutics
Shixin Pu, Pan Yang
2026-09 · DOI: 10.1016/j.jmccpl.2026.100864MicroRNAs and SGLT2 inhibitors in cardiovascular disease: Shared pathways and emerging roles
Anna Bjarvin Bhaskaran, Antoine Sakr, Desislava Doycheva
2026-09 · DOI: 10.1016/j.jmccpl.2026.100856SGLT2 inhibitor therapy is associated with IL-10/TGF-α/sVEGFR3 signalling and adipose tissue remodelling in advanced heart failure
Anna Cinkajzlova, Barbora Judita Kasperova, Peter Ivak, Ivan Netuka et al.
2026-09 · DOI: 10.1016/j.jmccpl.2026.100860Early cardiac proteomic profiling in a long-latency doxorubicin cardiomyopathy model exhibits sexual dimorphism for cardioprotection
Sogol Sedighi, Lijun Chen, Yuefen Wang, Kaui Lebarbenchon et al.
2026-09 · DOI: 10.1016/j.jmccpl.2026.100861Coronary artery disease in smokers with low traditional risk burden: An exploratory analysis of potential genetic susceptibility
Francisco Sousa, Maria Isabel Mendonça, João Adriano Sousa, Débora Sá et al.
2026-09 · DOI: 10.1016/j.jmccpl.2026.100855Absence of arrhythmogenic effects in cAMP subcellular compartments supports PDE8 as a target in atrial fibrillation
David Revuelta, Nefeli Grammatika Pavlidou, Cristina Aceituno, Issam Abu Taha et al.
2026-09 · DOI: 10.1016/j.jmccpl.2026.100871Immature and mature myocardium in the pathophysiology of hypertrophic cardiomyopathy
Jan M. Federspiel, Steven Lee Medarev, Jochen Pfeifer, Vivek P. Jani et al.
2026-09 · DOI: 10.1016/j.jmccpl.2026.100859Lamin B1 loss in human cardiomyocytes is associated with nuclear shape deformation in dilated cardiomyopathy
Leandro N. Ventimiglia, Aleksej Zelezniak, Cristobal G. dos Remedios, Sean Lal et al.
2026-09 · DOI: 10.1016/j.jmccpl.2026.100865The β1 adrenoceptor (AR) blocker metoprolol normalises βAR cascade and caveolar protein expression and restores β1AR responsiveness in failing right ventricular myocytes
Ruth Norman, Rachel Stones, Amelia S. Power, Ed White et al.
2026-09 · DOI: 10.1016/j.jmccpl.2026.100857JMCC Plus update: new opportunities, new collections, and continued growth
Davor Pavlovic, Rebekah Gundry
2026-06 · DOI: 10.1016/j.jmccpl.2026.100848RMC-6272, a selective third-generation bi-steric mTORC1 inhibitor, improves cardiac function in pressure overload-induced cardiac hypertrophy
Mariam Rogge, Johannes Fischer, Tobias Jakobi, Zoe Loewenthal et al.
2026-06 · DOI: 10.1016/j.jmccpl.2026.100847Doxorubicin exposure leads to cardiac fibroblast dysregulation and worsens fibrotic remodeling in the pathological heart
Sukriti Bagchi, Amy Cai, Alina S. Bilal, Javier Gamez-Luque et al.
2026-06 · DOI: 10.1016/j.jmccpl.2026.100846Reviews
Community Reviews
Version History
October 4, 2026 at 9:06 pm
October 2, 2026